Dizziness treatment device and system

Abstract

The application provides a dizziness treatment device and system, which comprises a dizziness type receiving module for receiving a dizziness type of a target patient containing dizziness symptom information; an acoustic audio generating module for generating a target acoustic audio according to the dizziness type and preset acoustic audio information corresponding to the dizziness symptom information; and an acoustic audio player for playing the target acoustic audio. According to the application, the dizziness type of the target patient is received, the target acoustic audio is generated according to the dizziness type and the preset acoustic audio information, and the target acoustic audio is played, so that the acoustic audio corresponding to the dizziness symptom is used to convert the acoustic signal into an electric signal and conduct the electric signal to the auditory center and other deep brain areas of the target patient, thereby regulating the brain function and the balance system, and achieving the treatment purpose by performing targeted treatment from the perspective of the disease cause and the disease mechanism, and improving the dizziness symptom and accompanying symptoms.

Description

Technical Field

[0001] This invention relates to the field of medical device technology, and in particular to a vertigo treatment device and system. Background Technology

[0002] Vertigo is a common vestibular dysfunction, primarily characterized by recurrent episodes of vertigo, with or without auditory impairment. The pathogenesis of vertigo is currently unclear. Because vertigo involves multiple departments and is an interdisciplinary field, it places high demands on physicians' research and understanding. In-depth multidisciplinary learning is required for a thorough understanding and accurate diagnosis. In fact, the misdiagnosis rate for vertigo is high, leading to a waste of medical resources. Patients suffer greatly during diagnosis and treatment, causing family and social problems.

[0003] Currently, the main treatment for vertigo is to use medication to treat various symptoms. For example, antiemetics such as promethazine are used for nausea and vomiting, and sedatives are used for fear and anxiety during acute attacks. However, existing drug treatments can only improve or alleviate symptoms during acute attacks and cannot target the underlying causes and mechanisms of the disease. This results in poor treatment efficacy, a high recurrence rate, and can cause serious psychological distress for patients, even inducing mental illnesses. Summary of the Invention

[0004] The purpose of this invention is to overcome the shortcomings of the prior art and provide a vertigo treatment device and system.

[0005] The present invention provides a vertigo treatment device, comprising:

[0006] A vertigo type receiving module is used to receive the vertigo type of a target patient containing vertigo symptom information, wherein the vertigo type includes vertigo treated with acoustic technology and vertigo treated with non-acoustic technology;

[0007] An acoustic audio generation module is used to generate target acoustic audio based on the dizziness type and preset acoustic audio information, wherein the preset acoustic audio information corresponds to the dizziness symptom information;

[0008] An acoustic audio player for playing the target acoustic audio.

[0009] Furthermore, it also includes:

[0010] A hearing feature acquisition module is used to acquire the hearing features of the target patient if the type of vertigo is vertigo treated by the acoustic technology. The hearing features include hearing loss and normal hearing, and the hearing loss includes at least one hearing loss frequency.

[0011] The acoustic audio generation module is also used for:

[0012] The target acoustic audio is generated based on the type of dizziness, the preset acoustic audio information, and the hearing characteristics.

[0013] Furthermore, the hearing feature acquisition module includes:

[0014] A hearing frequency acquisition unit is used to acquire at least one hearing loss frequency in the hearing loss if the type of vertigo is vertigo treated by the acoustic technology and the hearing characteristic is hearing loss.

[0015] The acoustic audio generation module is also used for:

[0016] Obtain the first sub-acoustic audio information corresponding to the hearing loss frequency from the preset acoustic audio information, and generate the target acoustic audio.

[0017] Furthermore, the acoustic audio generation module is also used for:

[0018] If there are multiple hearing loss frequencies, obtain multiple second sub-acoustic audio information corresponding to the hearing loss frequencies from the preset acoustic audio information;

[0019] The target acoustic audio is synthesized from multiple second sub-acoustic audio information.

[0020] Furthermore, the acoustic audio player is a dedicated acoustic playback device.

[0021] Furthermore, the acoustic audio player is a dedicated acoustic playback device.

[0022] The present invention also provides a vertigo treatment system, including the vertigo treatment device as described above.

[0023] Furthermore, it also includes:

[0024] A dizziness symptom input module is used to input the dizziness symptom information of the target patient;

[0025] The vertigo type confirmation module is used to determine the vertigo type of the target patient based on the vertigo symptom information and preset vertigo symptoms.

[0026] Furthermore, it also includes:

[0027] An electroencephalogram (EEG) detection module is used to detect the EEG of the target patient;

[0028] The first treatment assessment module is used to assess the target patient based on the electroencephalogram (EEG).

[0029] Furthermore, it also includes:

[0030] The symptom receiving module is used to receive symptom information input by the target patient;

[0031] The second treatment assessment module is used to assess the target patient based on the symptom information and a preset symptom scoring table.

[0032] The above technical solution has the following beneficial effects: by receiving the dizziness type of the target patient, generating target acoustic audio based on the dizziness type and preset acoustic audio information, and playing the target acoustic audio, the acoustic signal is converted into an electrical signal and transmitted to the auditory center and other deep brain regions of the target patient using the acoustic audio corresponding to the dizziness symptoms, thereby regulating brain function and balance system. This allows for targeted treatment from the perspective of the cause and pathogenesis of the disease, improving dizziness symptoms and their accompanying symptoms, achieving the therapeutic goal, and improving the treatment effect. Attached Figure Description

[0033] The disclosure of this invention will become more readily understood by referring to the accompanying drawings. It should be understood that these drawings are for illustrative purposes only and are not intended to limit the scope of protection of this invention. In the drawings:

[0034] Figure 1 This is a schematic diagram of the structure of a vertigo treatment device according to an embodiment of the present invention;

[0035] Figure 2 To adopt Figure 1 The diagram shows a comparison between the therapeutic effects of the vertigo treatment device and traditional drug treatment.

[0036] Figure 3 This is a schematic diagram of a vertigo treatment system provided in an embodiment of the present invention. Detailed Implementation

[0037] The specific embodiments of the present invention will be further described below with reference to the accompanying drawings.

[0038] It is readily understood that, based on the technical solution of this invention, various structural and implementation methods can be interchanged by those skilled in the art without altering the essential spirit of the invention. Therefore, the following detailed embodiments and accompanying drawings are merely illustrative examples of the technical solution of this invention and should not be considered as the entirety of the invention or as limitations or restrictions on the technical solution of the invention.

[0039] The directional terms such as up, down, left, right, front, back, front, back, top, and bottom mentioned or possibly used in this specification are defined relative to the structures shown in the accompanying drawings. They are relative concepts and may therefore vary depending on their location and usage. Therefore, these or other directional terms should not be interpreted as restrictive.

[0040] like Figure 1 As shown, a vertigo treatment device provided in one embodiment of the present invention includes:

[0041] The vertigo type receiving module 11 is used to receive the vertigo type of the target patient containing vertigo symptom information, wherein the vertigo type includes vertigo treated with acoustic technology and vertigo treated with non-acoustic technology;

[0042] The acoustic audio generation module 12 is used to generate target acoustic audio based on the dizziness type and preset acoustic audio information, wherein the preset acoustic audio information corresponds to the dizziness symptom information;

[0043] Acoustic audio player 13 is used to play the target acoustic audio.

[0044] The vertigo treatment device provided in this embodiment of the invention mainly includes a vertigo type receiving module 11, an acoustic audio generation module 12, and an acoustic audio player 13.

[0045] The vertigo type receiving module 11 is used to receive the vertigo type input by the target patient, which includes vertigo symptom information. The vertigo symptom information includes vestibular system symptoms, auditory system symptoms, head sensory abnormalities, visual symptoms, autonomic nervous system dysfunction symptoms, neuropsychiatric symptoms, poor mental state, sleep disorders, etc. The vertigo type can be determined by the target patient through a questionnaire based on preset vertigo symptoms. For example, when the target patient meets at least three of the vertigo symptom information at the same time, the vertigo type is acoustic technology treatment for vertigo; otherwise, the vertigo type is non-acoustic technology treatment for vertigo.

[0046] Acoustic therapy for vertigo refers to vertigo attacks accompanied by symptoms of neurological dysfunction, such as auditory symptoms, neuropsychiatric symptoms, and sleep disorders, and for which acoustic audio therapy is suitable. Non-acoustic therapy for vertigo refers to vertigo attacks accompanied only by vestibular symptoms, without other neurological dysfunction symptoms, and for which acoustic audio therapy is ineffective.

[0047] The acoustic audio generation module 12 is used to generate target acoustic audio based on the type of vertigo and preset acoustic audio information. The preset acoustic audio information corresponds to the vertigo symptom information and is preset in the acoustic audio generation module 12. If the vertigo type is vertigo treated with acoustic technology, the acoustic audio information corresponding to the vertigo symptom information in the preset acoustic audio information is selected to generate the target acoustic audio. If the vertigo type is vertigo treated without acoustic technology, that is, no acoustic technology treatment method is needed, the target acoustic audio is empty.

[0048] The acoustic audio player 13 is used to play target acoustic audio. If the vertigo is treated with acoustic technology, the target patient wears the acoustic audio player 13 to play the target acoustic audio. The acoustic audio player 13 can adjust the volume and playback time of the acoustic audio, converting the acoustic signal into an electrical signal and transmitting it to the target patient's auditory center and other deep brain regions, thereby regulating brain function and the balance system, improving vertigo symptoms and their accompanying symptoms, achieving the therapeutic goal. The effective treatment rate can reach over 80%. Figure 2 As shown in the experimental data, the vertigo treatment device (acoustic audio) provided by this invention can control vertigo in over 80% of cases and improve mood in over 70% of cases. In contrast, traditional drug treatment can only control vertigo in over 50% of cases and improve mood in only about 45% of cases.

[0049] The vertigo treatment device provided by this invention receives the vertigo type of the target patient, generates a target acoustic audio based on the vertigo type and a preset acoustic audio, and plays the target acoustic audio. By using the acoustic audio corresponding to the vertigo symptoms, the acoustic signal is converted into an electrical signal and transmitted to the auditory center and other deep brain regions of the target patient, thereby regulating brain function and the balance system. It can provide targeted treatment from the perspective of the cause and pathogenesis of the disease, improve vertigo symptoms and their accompanying symptoms, achieve the therapeutic goal, and improve the therapeutic effect.

[0050] In one embodiment, it further includes:

[0051] The hearing feature acquisition module 14 is used to acquire the hearing features of the target patient if the type of vertigo is vertigo treated by the acoustic technology. The hearing features include hearing loss and normal hearing, and the hearing loss includes at least one hearing loss frequency.

[0052] The acoustic audio generation module 12 is also used for:

[0053] The target acoustic audio is generated based on the type of dizziness, the preset acoustic audio information, and the hearing characteristics.

[0054] The hearing feature acquisition module 14 is used to acquire the hearing features of the target patient based on audiology if the vertigo type is acoustic technology treatment for vertigo. The hearing features include hearing loss and normal hearing, and the hearing loss includes at least one hearing loss frequency.

[0055] The acoustic audio generation module 12 generates target acoustic audio based on the type of vertigo, preset acoustic audio information, and hearing characteristics. For example, if the type of vertigo is vertigo treated with acoustic technology and the hearing characteristic is hearing loss, the module selects acoustic audio information from the preset acoustic audio information that corresponds to the vertigo symptom information and the frequency corresponding to the hearing loss frequency to generate the target acoustic audio. If the type of vertigo is vertigo treated with acoustic technology and the hearing characteristic is normal hearing, the module selects acoustic audio information from the preset acoustic audio information that corresponds to the vertigo symptom information to generate the target acoustic audio, thereby further achieving targeted treatment and improving the treatment effect.

[0056] In one embodiment, the hearing feature acquisition module 14 includes:

[0057] The hearing frequency acquisition unit 141 is used to acquire at least one hearing loss frequency in the hearing loss if the type of vertigo is vertigo treated by the acoustic technology and the hearing characteristic is hearing loss.

[0058] The acoustic audio generation module 12 is also used for:

[0059] Obtain the first sub-acoustic audio information corresponding to the hearing loss frequency from the preset acoustic audio information, and generate the target acoustic audio.

[0060] The hearing frequency acquisition unit 141 is used to acquire at least one hearing loss frequency if the vertigo type is acoustic technology treatment for vertigo and the hearing characteristic is hearing loss. The acoustic audio generation module 12 is also used to acquire the first sub-acoustic audio information corresponding to the hearing loss frequency in the preset acoustic audio information and generate the target acoustic audio. For example, if the vertigo type is acoustic technology treatment for vertigo and the hearing loss frequency is 40-60Hz, the first sub-acoustic audio information with a frequency of 40-60Hz in the preset acoustic audio information is acquired and the target acoustic audio is generated, thereby achieving targeted treatment and further improving the treatment effect.

[0061] In one embodiment, the acoustic audio generation module 12 is further configured to:

[0062] If there are multiple hearing loss frequencies, obtain multiple second sub-acoustic audio information corresponding to the hearing loss frequencies from the preset acoustic audio information;

[0063] The target acoustic audio is synthesized from multiple second sub-acoustic audio information.

[0064] If there are multiple frequencies of hearing loss, such as 125-500Hz, 500-4000Hz, 4000-8000Hz, etc., the acoustic audio generation module 12 acquires the second acoustic audio information with frequencies of 125-500Hz, 500-4000Hz, 4000-8000Hz, etc. from the preset acoustic audio information, and synthesizes the second acoustic audio information with frequencies of 125-500Hz, 500-4000Hz, 4000-8000Hz, etc. together to form the target acoustic audio, thereby achieving targeted treatment and further improving the treatment effect.

[0065] In one embodiment, the acoustic audio player 13 is a dedicated acoustic playback device.

[0066] If the hearing characteristic is hearing loss, the acoustic audio player 13 is a dedicated acoustic playback device, thereby enabling the playback of target acoustic audio for different target patients, achieving targeted treatment and further improving the treatment effect.

[0067] In one embodiment, the acoustic audio player 13 is a pair of headphones for easy playback of the target acoustic audio.

[0068] If the hearing characteristics are normal, the acoustic audio player 13 is an earphone, thereby enabling the playback of target acoustic audio for different target patients, achieving targeted treatment and further improving the treatment effect.

[0069] Headphones refer to devices that can play acoustic audio frequencies in the range of 20-20000Hz.

[0070] In one embodiment, it further includes:

[0071] Memory 15 is used to store the target acoustic audio.

[0072] The memory 15 is used to store the target acoustic audio generated by the acoustic audio generation module 12. It can also store the correspondence between the target patient and / or dizziness symptom information and the target acoustic audio, so as to facilitate the subsequent playback of the target acoustic audio corresponding to the target patient and / or dizziness symptom information. For example, when the target patient undergoes a second treatment, the stored target acoustic audio corresponding to the target patient can be played directly through the acoustic audio player 13. Also, when the dizziness symptom information of the target patient is the same as or similar to the dizziness symptom information corresponding to the target acoustic audio stored in the memory 15, the stored target acoustic audio can be played directly through the acoustic audio player 13 without having to obtain the dizziness symptom information of the target patient and generate the target acoustic audio multiple times, thereby improving work efficiency.

[0073] like Figure 3As shown, an embodiment of the present invention provides a vertigo treatment system, including the vertigo treatment device 10 as described above.

[0074] The vertigo treatment system provided by this invention receives the vertigo type of the target patient, generates target acoustic audio based on the vertigo type and preset acoustic audio information, and plays the target acoustic audio. By using acoustic audio corresponding to the vertigo symptoms, the acoustic signal is converted into an electrical signal and transmitted to the auditory center and other deep brain regions of the target patient, thereby regulating brain function and balance system. It can provide targeted treatment from the perspective of the cause and pathogenesis of the disease, improve vertigo symptoms and their accompanying symptoms, achieve the therapeutic goal, and improve the treatment effect.

[0075] In one embodiment, it further includes:

[0076] The dizziness symptom input module 21 is used to input the dizziness symptom information of the target patient;

[0077] The vertigo type confirmation module 22 is used to determine the vertigo type of the target patient based on the vertigo symptom information and preset vertigo symptoms.

[0078] The dizziness symptom input module 21 can use a questionnaire to allow the target patient to input dizziness symptom information according to preset dizziness symptoms. The dizziness symptom information includes vestibular system symptoms, auditory system symptoms, abnormal head sensation symptoms, visual symptoms, autonomic nervous system dysfunction symptoms, neuropsychiatric symptoms, poor mental state, sleep disorders, etc.

[0079] The vertigo type confirmation module 22 is used to determine the vertigo type of the target patient based on vertigo symptom information and preset vertigo symptoms. Vertigo types include vertigo treated with acoustic technology and vertigo treated with non-acoustic technology. For example, when the target patient meets at least three of the vertigo symptom information at the same time, the vertigo type is vertigo treated with acoustic technology; otherwise, the vertigo type is vertigo treated with non-acoustic technology. This determines the vertigo type, enables rapid vertigo diagnosis, improves efficiency, avoids the waste of a large amount of medical resources due to misdiagnosis, and achieves a combination of treatment and diagnosis to further improve the treatment effect.

[0080] Acoustic therapy for vertigo refers to vertigo attacks accompanied by symptoms of neurological dysfunction, such as auditory symptoms, neuropsychiatric symptoms, and sleep disorders, and for which acoustic audio therapy is suitable. Non-acoustic therapy for vertigo refers to vertigo attacks accompanied only by vestibular system symptoms, without other neurological dysfunction symptoms, and for which acoustic audio therapy is ineffective.

[0081] In one embodiment, it further includes:

[0082] Electroencephalogram (EEG) detection module 23 is used to detect the EEG of the target patient;

[0083] The first treatment assessment module 24 is used to assess the target patient based on the electroencephalogram (EEG).

[0084] Electroencephalogram (EEG) detection module 23

[0085] The electroencephalogram (EEG) detection module 23 is used to detect the EEG of the target patient. The EEG detection module 23 can use existing EEG detection equipment, so its specific structure will not be described in detail here.

[0086] The first treatment assessment module 24 is used to assess the treatment effect of the target patient after vertigo treatment using the above-mentioned vertigo treatment device based on the electroencephalogram (EEG). For example, the treatment effect is judged based on whether there are abnormalities in the EEG. If there are no abnormalities in the EEG, it indicates that the treatment effect has been achieved. If there are abnormalities in the EEG, it indicates that one or more acoustic technology treatments are needed to further ensure the treatment effect and achieve timely monitoring.

[0087] In one embodiment, it further includes:

[0088] Symptom receiving module 25 is used to receive symptom information input by the target patient;

[0089] The second treatment assessment module 26 is used to assess the target patient based on the symptom information and a preset symptom scoring table.

[0090] The symptom receiving module 25 is used to receive symptom information input by the target patient in the form of a questionnaire based on preset vertigo symptoms after the target patient has undergone vertigo treatment using the above-mentioned vertigo treatment device.

[0091] The second treatment assessment module 26 assesses the treatment effect of the target patient based on the symptom information input by the target patient and the preset symptom scoring table, thereby further ensuring the treatment effect and achieving timely monitoring.

[0092] The preset symptom scoring table can adopt the existing standard vertigo patient scoring table. The existing standard vertigo patient scoring table is preset in the second treatment assessment module 26. The specific structure and content of the standard vertigo patient scoring table will not be described here.

[0093] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the embodiments of the present invention, and are not intended to limit them. Although the embodiments of the present invention have been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A vertigo treatment device, characterized in that, include: A vertigo type receiving module is used to receive the vertigo type of a target patient containing vertigo symptom information. The vertigo type includes vertigo treated with acoustic technology and vertigo treated with non-acoustic technology. Vertigo treated with acoustic technology refers to vertigo attacks accompanied by symptoms of functional impairment of the brain nerves. Vertigo treated with non-acoustic technology refers to vertigo attacks accompanied only by vestibular system symptoms, and vertigo for which acoustic audio therapy is ineffective. An acoustic audio generation module is used to generate a target acoustic audio based on the dizziness type and preset acoustic audio information, wherein the preset acoustic audio information corresponds to the dizziness symptom information: if the dizziness type is dizziness treated by the acoustic technology, the acoustic audio information corresponding to the dizziness symptom information in the preset acoustic audio information is selected to generate the target acoustic audio; If the type of vertigo is vertigo treated with non-acoustic techniques, the target acoustic audio is empty; An acoustic audio player for playing the target acoustic audio.

2. The vertigo treatment device as described in claim 1, characterized in that, Also includes: A hearing feature acquisition module is used to acquire the hearing features of the target patient if the type of vertigo is vertigo treated by the acoustic technology. The hearing features include hearing loss and normal hearing, and the hearing loss includes at least one hearing loss frequency. The acoustic audio generation module is also used for: The target acoustic audio is generated based on the dizziness type, the preset acoustic audio information, and the hearing characteristics.

3. The vertigo treatment device as described in claim 2, characterized in that, The hearing feature acquisition module includes: A hearing frequency acquisition unit is used to acquire at least one hearing loss frequency in the hearing loss if the type of vertigo is vertigo treated by the acoustic technology and the hearing characteristic is hearing loss. The acoustic audio generation module is also used for: Obtain the first sub-acoustic audio information corresponding to the hearing loss frequency from the preset acoustic audio information, and generate the target acoustic audio.

4. The vertigo treatment device as described in claim 3, characterized in that, The acoustic audio generation module is also used for: If there are multiple hearing loss frequencies, obtain multiple second sub-acoustic audio information corresponding to the hearing loss frequencies from the preset acoustic audio information; The target acoustic audio is synthesized from multiple second sub-acoustic audio information.

5. The vertigo treatment device as described in claim 4, characterized in that, The acoustic audio player is a dedicated acoustic playback device.

6. The vertigo treatment device as described in claim 1, characterized in that, The acoustic audio player is a pair of headphones.

7. A vertigo treatment system, characterized in that, Includes the vertigo treatment device as described in any one of claims 1-6.

8. The vertigo treatment system as described in claim 7, characterized in that, Also includes: A dizziness symptom input module is used to input the dizziness symptom information of the target patient; The vertigo type confirmation module is used to determine the vertigo type of the target patient based on the vertigo symptom information and preset vertigo symptoms.

9. The vertigo treatment system as described in claim 7 or 8, characterized in that, Also includes: An electroencephalogram (EEG) detection module is used to detect the EEG of the target patient; The first treatment assessment module is used to assess the target patient based on the electroencephalogram (EEG).

10. The vertigo treatment system as described in claim 7 or 8, characterized in that, Also includes: The symptom receiving module is used to receive symptom information input by the target patient; The second treatment assessment module is used to assess the target patient based on the symptom information and a preset symptom scoring table.

Images